TDCS transcranial electrical stimulator

for chronic pain treatment

Overview
The HOME tDCS device by Ionclinics is a portable medical transcranial direct current stimulation system CE‑certified for home use. It is designed to deliver physician‑prescribed, evidence‑based tDCS protocols with an intuitive interface that reduces user errors and supports consistent at‑home therapy.

Key benefits

• Enables home‑based neuromodulation sessions under physician‑designed protocols.
• Reduces clinic visits and increases cumulative therapy time.
• Improves resource use by limiting patient travel to the clinic.
• Interface and workflow designed to minimise delivery errors.
• Supported by clinical experience and scientific literature.
• Device certified for unattended home use for its indicated conditions.

Regulatory & safety
The device is CE certified for medical use (MDR CE1936) for home application and is indicated for use without continuous healthcare professional supervision for its certified indications, in accordance with the certification.

Clinical evidence & positioning
tDCS has an extensive body of clinical and scientific evidence across several neurological and psychiatric conditions. HOME tDCS is positioned to enable more frequent, higher‑intensity treatment schedules in the patient’s home, which may support improved adherence and therapeutic outcomes when used according to clinical guidance.

Clinical applications

• Major Depressive Disorder — stimulation of the dorsolateral prefrontal cortex to reduce depressive symptoms; home delivery supports patients with limited mobility.
• Chronic Pain & Fibromyalgia — non‑pharmacological modulation of pain‑related networks allowing more consistent treatment at home.
• Neuropathic Pain — modulation of neural circuits implicated in neuropathic pain to reduce symptoms.
• Stroke — facilitates neuroplasticity to support motor and cognitive rehabilitation with increased session frequency.
• Schizophrenia — adjunctive neuromodulation to target symptoms and cognitive deficits as part of a broader treatment plan.
• Parkinson — adjunctive use to complement conventional therapies for motor and non‑motor symptoms.

Usability & advanced features

• Designed for safe, guided home use with a user‑centred interface that supports protocol adherence.
• Facilitates remote delivery models where prescribed protocols are authorised by a healthcare professional.
• Clinical testimonials and case reports are available as professional references supporting home application.

Caractéristiques / spécifications techniques

• Denomination commerciale: HOME tDCS
• Device type: Portable medical tDCS device for home use
• Regulation: MDR CE1936 certified for home use
• Indications certified (six therapeutic indications): Major Depressive Disorder; Chronic Pain & Fibromyalgia; Neuropathic Pain; Stroke rehabilitation; Schizophrenia; Parkinson
• Usability: Intuitive design to minimise delivery errors and enable patients to follow physician‑designed protocols at home
• Clinical support: Backed by clinical experience and scientific research
• Therapy model: Enables more intensive and frequent home sessions to maximise therapy time and reduce clinic visits
• Product documentation: Product sheet available (downloadable product sheet referenced on page)